By Ben Glickman Shares of ALX Oncology rose Monday after the company said it would discuss interim Phase 2 trial results on a call Tuesday. The stock was up.
By Dean Seal One of ALX Oncology's board members has taken over as chief executive as founder Jaume Pons transitions into a new role as chief scientific.